EV/EBITDA
-7.95
+0.09+1.12%
7 min ago
Summary
- As of February 7, 2025, NAMS EV/EBITDA is -7.95, with a rise of +0.09 (+1.12%) during the most recent trading day.
- Over the past year, NAMS EV/EBITDA has dropped by -0.27 (-3.52%).
- NAMS EV/EBITDA is now -142.38% below its all-time high of -3.28.
Performance
NAMS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NAMS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.1% | -1.1% | -0.8% |
| 1 m1 month | +26.7% | -26.7% | -21.9% |
| 3 m3 months | +9.3% | -9.4% | -7.4% |
| 6 m6 months | -66.7% | +46.8% | +28.5% |
| ytdytd | +26.4% | -26.4% | -21.7% |
| 1 y1 year | -3.5% | +5.8% | -2.3% |
| 5 y5 years | - | - | - |
NAMS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -10.87 | +26.9% | |
| 3 m | 3-month | -6.90 | -15.2% | -11.65 | +31.8% |
| 6 m | 6-month | -4.68 | -69.9% | -11.65 | +31.8% |
| 1 y | 1-year | -4.68 | -69.9% | -11.65 | +31.8% |
| 3 y | 3-year | -3.28 | -142.4% | -11.65 | +31.8% |
| 5 y | 5-year | -3.28 | -142.4% | -11.65 | +31.8% |
| alltime | all time | -3.28 | -142.4% | -11.65 | +31.8% |
NewAmsterdam Pharma Company NV EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -7.95(-26.4%) |
| Date | Value |
|---|---|
| 2024 | -10.80(+229.3%) |
| 2023 | -3.28 |
FAQ
- What is NewAmsterdam Pharma Company NV EV/EBITDA?
- What is the all time high EV/EBITDA for NewAmsterdam Pharma Company NV?
- What is NAMS EV/EBITDA year-to-date change?
- What is NewAmsterdam Pharma Company NV EV/EBITDA year-on-year change?
What is NewAmsterdam Pharma Company NV EV/EBITDA?
The current EV/EBITDA of NAMS is -7.95
What is the all time high EV/EBITDA for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high EV/EBITDA is -3.28
What is NAMS EV/EBITDA year-to-date change?
NewAmsterdam Pharma Company NV EV/EBITDA has changed by +2.85 (+26.39%) since the beginning of the year
What is NewAmsterdam Pharma Company NV EV/EBITDA year-on-year change?
Over the past year, NAMS EV/EBITDA has changed by -0.27 (-3.52%)